We work only with long-established manufacturing partners and maintain clear documentation for every peptide we supply
HCP Considerations If group GLP-1 RA starts are going to be introduced for diabetes care the following factors have been identified by the MDT team
Attempting to self-administer an unlicensed substance without medical supervision is potentially dangerous and may also delay access to safe, effective, and evidence-based treatments that are already available
Elevate Health May Align Well With People Who: Prefer telehealth convenience over in-person care: If your schedule makes regular clinic visits difficult, or if you're comfortable with virtual consultations and self-administration of medications, Elevate Health's fully remote model may fit your lifestyle
Montlick is investigating GLP-1 drug injury claims and providing free, confidential consultations to review your individual circumstances
Questions to ask yourself before enrolling: Have I discussed GLP-1 medications with my primary care physician, including whether an FDA-approved option might be appropriate for me
